Culver Capital Investment Banking

Specialty Pharmaceutical

Making Scientific Advances Affordable

Not all biotechnology products have to be a financial burden for a consumer and their family. Many of today’s most effective therapies are approved by the FDA as over-the-counter (OTC) or as a prescription generic. Capital is still required for the strict manufacturing, marketing and regulatory process involved in these specialty pharmaceuticals.

To aid in this capital raising, CB will represent specialty pharmaceutical companies to its network of investors that deal with companies ranging from generic drug makers to companies specializing in women’s health.

Below are examples of specialty pharmaceutical companies that CB will represent

  • Generic Pharmaceutical
  • Biosimilar
  • Womens Health
  • OTC